Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
D12 is a brain-penetrant ferroptosis inhibitor.1 It inhibits ferroptosis induced by RSL3 (Item No. 19288) in PC12 cells (EC50 = 39.7 nM) by reducing oxidative stress and lipid peroxidation, thereby reducing RSL3-mediated compensatory activation of Nrf2. It also inhibits ferroptosis induced by erastin (Item No. 17754) in PC12 cells (EC50 = 410 nM). Intraperitoneal administration of D12 (10 and 20 mg/kg) restores hepatic glutathione (GSH) and malondialdehyde (MDA) levels and reduces liver injury induced by acetaminophen (Item No. 10024) in a mouse model of acute liver injury. It also reduces infarct volume and neurological deficits in a rat model of cerebral ischemia-reperfusion injury when administered intravenously at 1 mg/kg.
WARNING This product is not for human or veterinary use.
1. Design, synthesis, and evaluation of indolizine derivatives as nonclassical ferroptosis inhibitors with efficacy in acute liver injury and ischemic stroke models. J. Med. Chem. 69(7), 8051-8074 (2026).